Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McEntyre

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biological Chemistry|December 1, 2016
Is N,N-dimethylglycine N-oxide a choline and betaine metabolite?Michael Lever, Christopher J McEntyre, Peter M George, et al.
The Clinical Biochemist. Reviews|April 1, 2011
Trimethylaminuria: causes and diagnosis of a socially distressing conditionRichard J Mackay, Christopher J McEntyre, Caroline Henderson, et al.
The Australian and New Zealand Journal of Surgery|September 1, 1987
Electrical stimulation in the treatment of chronic venous ulcerationP M Katelaris, J P Fletcher, J M Little, et al.
Journal of Clinical Lipidology|August 12, 2014
Fenofibrate causes elevation of betaine excretion but not excretion of other osmolytes by healthy adultsMichael Lever, Christopher J McEntyre, Peter M George, et al.
Therapeutic Drug Monitoring|November 16, 2018
Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab- and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution AssayBarry D Hock, Judith L McKenzie, Liping Goddard, et al.
Journal of Immunological Methods|September 17, 2019
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serumBarry D Hock, Stewart M Smith, Christopher J McEntyre, et al.
Cardiovascular Drugs and Therapy|July 26, 2014
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytesMichael Lever, Christopher J McEntyre, Peter M George, et al.
Annals of Clinical Biochemistry|July 12, 2014
Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year periodChristopher J McEntyre, Michael Lever, Stephen T Chambers, et al.
Plos One|December 11, 2014
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational StudyMichael Lever, Peter M George, Sandy Slow, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biological Chemistry|December 1, 2016
Is N,N-dimethylglycine N-oxide a choline and betaine metabolite?Michael Lever, Christopher J McEntyre, Peter M George, et al.
The Clinical Biochemist. Reviews|April 1, 2011
Trimethylaminuria: causes and diagnosis of a socially distressing conditionRichard J Mackay, Christopher J McEntyre, Caroline Henderson, et al.
The Australian and New Zealand Journal of Surgery|September 1, 1987
Electrical stimulation in the treatment of chronic venous ulcerationP M Katelaris, J P Fletcher, J M Little, et al.
Journal of Clinical Lipidology|August 12, 2014
Fenofibrate causes elevation of betaine excretion but not excretion of other osmolytes by healthy adultsMichael Lever, Christopher J McEntyre, Peter M George, et al.
Therapeutic Drug Monitoring|November 16, 2018
Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab- and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution AssayBarry D Hock, Judith L McKenzie, Liping Goddard, et al.
Journal of Immunological Methods|September 17, 2019
Development of a competitive binding homogeneous mobility shift assay for the quantification of adalimumab levels in patient serumBarry D Hock, Stewart M Smith, Christopher J McEntyre, et al.
Cardiovascular Drugs and Therapy|July 26, 2014
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytesMichael Lever, Christopher J McEntyre, Peter M George, et al.
Annals of Clinical Biochemistry|July 12, 2014
Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year periodChristopher J McEntyre, Michael Lever, Stephen T Chambers, et al.
Plos One|December 11, 2014
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational StudyMichael Lever, Peter M George, Sandy Slow, et al.
Pageof 2